Literature DB >> 2434417

Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro.

J Gauldie, D N Sauder, K P McAdam, C A Dinarello.   

Abstract

A universal component of inflammation is the increased synthesis of a series of plasma proteins (acute-phase proteins) by the liver. The postulated messenger of acute-phase protein induction is released by leucocytes at the site of inflammation and has been shown to co-purify with endogenous pyrogen or lymphocyte-activating factor. Interleukin-1, molecular weight 17,000, pI 6 X 8-7 X 2, was purified to homogeneity from adherent human blood monocytes by a combination of affinity chromatography, gel filtration and isoelectric focusing. We examined the direct effect of pure IL-1 on the induction of acute-phase protein synthesis in vitro using rat and mouse hepatocytes. IL-1 caused significant increased synthesis of alpha 1-acid glycoprotein and smaller increases in the synthesis of other acute-phase proteins, and significant decreased synthesis of albumin. The pattern of induction of acute-phase proteins differs from that seen with a separate 30,000 molecular weight hepatocyte-stimulating factor from human monocytes described previously. We conclude that human IL-1 is one of the mediators responsible for the acute-phase protein response of the liver in inflammation and can directly cause stimulation of specific gene expression in normal hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434417      PMCID: PMC1453219     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Messenger RNA activities of four acute phase proteins during inflammation.

Authors:  W Northemann; T Andus; V Gross; M Nagashima; G Schreiber; P C Heinrich
Journal:  FEBS Lett       Date:  1983-09-19       Impact factor: 4.124

2.  Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein.

Authors:  D G Ritchie; G M Fuller
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

Review 3.  The numerous postulated biological manifestations of interleukin-1.

Authors:  R F Kampschmidt
Journal:  J Leukoc Biol       Date:  1984-09       Impact factor: 4.962

Review 4.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

5.  Interleukin 1 as mediator of the acute-phase response.

Authors:  C A Dinarello
Journal:  Surv Immunol Res       Date:  1984

6.  The acute phase response of plasma protein synthesis during experimental inflammation.

Authors:  G Schreiber; G Howlett; M Nagashima; A Millership; H Martin; J Urban; L Kotler
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

7.  Studies on the effect of inflammation on rat liver and serum sialyltransferase. Evidence that inflammation causes release of Gal beta 1 leads to 4GlcNAc alpha 2 leads to 6 sialyltransferase from liver.

Authors:  H A Kaplan; B M Woloski; M Hellman; J C Jamieson
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

8.  Changes in the blood level and affinity to concanavalin A of rat plasma glycoproteins during acute inflammation and hepatoma growth.

Authors:  A Koj; A Dubin; H Kasperczyk; J Bereta; A H Gordon
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

Review 9.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

10.  Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse.

Authors:  H Baumann; G P Jahreis; D N Sauder; A Koj
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

View more
  15 in total

1.  Pro-inflammatory cytokines expression increases following low- and high-magnitude cyclic loading of lumbar ligaments.

Authors:  Peter D'Ambrosia; Karen King; Bradley Davidson; Bing He Zhou; Yun Lu; Moshe Solomonow
Journal:  Eur Spine J       Date:  2010-03-25       Impact factor: 3.134

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 3.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

4.  Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

Authors:  P A Guerne; B L Zuraw; J H Vaughan; D A Carson; M Lotz
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

5.  Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepatocytes.

Authors:  T Hagiwara; H Suzuki; I Kono; H Kashiwagi; Y Akiyama; K Onozaki
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

6.  Effects of monocytic products, recombinant interleukin-1, and recombinant interleukin-6 on glycosylation of alpha 1-acid glycoprotein: studies with primary human hepatocyte cultures and rats.

Authors:  O Pos; H J Moshage; S H Yap; J P Snieders; L A Aarden; J van Gool; W Boers; A M Brugman; W van Dijk
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

7.  Stimulation of the acute-phase response in simian virus 40-hepatocyte cell lines.

Authors:  W S Liao; K T Ma; C D Woodworth; L Mengel; H C Isom
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

8.  Identification of sequences responsible for acute-phase induction of human C-reactive protein.

Authors:  R Arcone; G Gualandi; G Ciliberto
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

9.  Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis.

Authors:  Linda L Hushaw; Ray Sawaqed; Ghaleb Sweis; Jori Reigle; Anjali Gopal; Daniel Brandt; Nadia Sweis; James Curran; Timothy B Niewold; Nadera J Sweiss
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

10.  Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production.

Authors:  L Borish; M S King; J J Mascali; S Johnson; B Coll; L J Rosenwasser
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.